Biotech stocks get a boost, or plunge, as new clinical data is shared before major cancer meeting

This includes Arcellx, Iovance Biotherapeutics, and ZymeWorks.
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.